Across discovery and validation cohorts, this work shows that TERT expression separates pulmonary carcinoids into biologically and clinically distinct groups. High TERT expression is associated with more aggressive disease behavior and poorer outcome, supporting TERT as a practical prognostic marker in these tumors.